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A B S T R A C T
Zinc has been proven to be anticonvulsant in several studies which indicate that diphenylthiocarbazone
(dithizone) and diethyldithiocarbamate (DEDTC), zinc chelating agents, enhance seizure activities. There
is also evidence that nitric oxide (NO) generators increase zinc concentration in the brain. On the other
hand, the increased level of NO in the nervous system and the consequently increased seizure threshold
in cholestatic mice have been well studied. Thus, it could be hypothesized that one of the reasons for the
increased seizure threshold in cholestasis is partly the enhanced endogenous zinc concentration, at least
in part, due to the overproduction of NO. In this study, we examined the hypothesis that zinc chelating
agents might decrease seizure activity to its pre-cholestatic level in bile duct-ligated (BDL) mice. Mice
were intra-peritoneally injected with dithizone and diethyldithiocarbamate (DEDTC) before the
induction of seizure by pentylenetetrazole (PTZ) and then the seizure activity was recorded. Dose
response (dithizone: 5, 30, 100 and 200 mg/kg; DEDTC: 25, 50 and 100 mg/kg) and time course (only for
dithizone: 15, 30, 60 and 120 min) studies were performed ﬁrst. Then, the effects of cholestasis, with and
without dithizone injection, on seizure activity were assessed. Proconvulsant effect of dithizone and
DEDTC was proved to be dose dependent although time interval between dithizone and PTZ injections
did not play any signiﬁcant role in the seizure activity. Cholestasis decreased seizure activity and
increased lag phase before seizure and both effects were decreased by dithizone injection. It is elicited
that zinc may mediate the cholestasis-induced decrement in seizure activity.
 2008 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Zinc plays various roles in biological systems1–4 and in the
pathophysiology of central nervous system (CNS) diseases such as
Alzheimer’s disease, cerebral ischemia and epilepsy.5–9 It has been
found that it acts either as an anticonvulsant10 or as a
proconvulsant agent11 depending on the type of seizure, animal
species and convulsant agents.12–14 It has been shown that
intracerebroventricular injection of zinc not only increases
audiogenic seizure susceptibility in mice15 but also causes
epileptic seizures in rats.11,16–18 On the other hand, audiogenic
seizure activity was decreased by subcutaneous injection of zinc.19
Beside these controversial actions of exogenous zinc, an antic-
onvulsant action for endogenous zinc has been proposed.20 Thus,* Corresponding author. Tel.: +98 21 6680 1062; fax: +98 21 6680 1064.
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(A. Kebriaeezadeh).
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doi:10.1016/j.seizure.2008.06.004systemic administration of metal chelating agents, DEDTC and
diphenylthiocarbazone (dithizone), decreases the lag phase before
the induction of seizure by intra-peritoneal (i.p.) injection of
kainate or electrical stimulation, which can be explained by their
penetration into the brain and binding to the endogenous zinc.20–
23 Studies with Timm’s sulﬁde-silver staining also revealed
reduced zinc content in hippocampus after using mentioned
chelating agents.20,24–26 However, the function of vesicular zinc is
not well understood.27
It has been proved that administrating nitric oxide (NO)
generators results in accumulation of chelatable zinc in hippo-
campal neuronal perikarya.4,24,28 In addition, an anticonvulsant
role for NO has been reported.29 More interestingly, cholestasis
leads to NO overproduction30–32 and also increases levels of
hepatic and serum zinc at 24 h after bile duct ligation.33 On the
other hand, pentylenetetrazole (PTZ)-induced seizure threshold
has been reported to increase in cholestatic mice and it has been
suggested to be due to increased opioidergic tone and NO level.32
Notably, there are also some interactions between endogenousEpilepsy Association.
Table 1
Seizure severity scoring
Score Behavioral response
0 No response
1 Staring/unresponsive
2 Focal clonic convulsion (e.g. head nod/twitch/myoclonic jerk/backing)
3 Forelimb clonus
4 Rearing
5 Loss of posture (e.g. jumping/rearing and falling)
6 Status epilepticus/death
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assess the effects of zinc chelating agents on the cholestasis-
induced changes in seizure activity. As a result, we should expect
zinc chelating agents to decrease the cholestasis-induced incre-
ment of seizure threshold to its pre-cholestatic level.
2. Materials and methods
2.1. Chemicals
The following drugs were used throughout the study: pentyle-
netetrazole (Sigma, U.K.), diethyldithiocarbamate (Sigma, U.K.),
diphenylthiocarbazone (Fluka, Switzerland), ketamineHCL(Alfasan,
Woerden, Holland) and chlorpromazineHCL (Daroupakhsh, Tehran,
Iran). Dithizone was dissolved in dimethylsulfoxide (DMSO) and
DEDTC was prepared in 0.9% saline and their pHwas adjusted to 7–
7.4. PTZ was prepared in phosphate buffered saline (18 mg/ml
adjusted to pH 7.4). All injections were done intra-peritoneally and
in volumes of no more than 10 ml/kg of the body weight of mice.
2.2. Animal model of cholestasis: bile duct ligation (BDL)
Male NMRI mice (20–25 g, Pasteur Institute) were used
throughout this study. The animals were housed in a tempera-
ture-controlled room (25  1 8C) on a 12 h light/dark cycle with free
access to food and water. All experiments were performed in
accordance with institutional guidelines for animal care and use and
also ‘‘Principles of laboratory animal care’’ were followed.
Procedures were done as fully described in previous studies at
our department.36,37 In brief, mice were laparatomized under
general anesthesia induced by ketamine (50 mg/kg) and chlorpro-
mazine (10 mg/kg). Bile ductwas left in situ aftermanipulationwith
forceps in sham-operated animals. In BDL animals, the bile ductwas
doubly ligatedand thenabdominal incisionwas closed in two layers.
2.3. Study design
From surgical point of view, each experimental group can be
considered into one these three groups: (i) unoperated (UNOP), (ii)
sham-operated (SHAM) and (iii) bile duct-ligated (BDL) groups.
Each mouse was used only once and each experimental group
contained at least seven animals.
2.3.1. Experiment I
A group of unoperated mice was injected PTZ (50 mg/kg) and
evaluated as the control group to which vehicle-injected groups
were to compare. Five groups of mice were injected DMSO (vehicle
group) and different doses of dithizone (5, 30, 100 and 200 mg/kg)
intra-peritoneally. After 15 min theywere injected PTZ (50 mg/kg).
In addition, another four groups ofmicewere injected vehicle (0.9%
saline) or different doses of DEDTC (25, 50 and 100 mg/kg) intra-
peritoneally. After 30 min these mice were injected PTZ (50 mg/
kg).20
2.3.2. Experiment II
Between two metal chelating agents mentioned above (dithi-
zone and DEDTC), dithizone was chosen for the rest of the study
because both of them had similar effects on seizure activity in
experiment I. In the second experiment constant dosage of
dithizone (100 mg/kg) was injected followed by i.p. PTZ (50 mg/
kg) injection after different time intervals: 15, 30, 60 and 120 min.
2.3.3. Experiment III
By having scored the BDL, sham-operated and unoperated
controls (60 mg/kg of PTZ) groups, we evaluated the effect ofcholestasis on seizure activity. To ﬁnd the maximum effect of
cholestasis on maximum seizure severity score (MSSS) in this
model of seizure, four groups of BDL mice were injected PTZ after
different time intervals from operation: 24, 48, 72 and 120 h. The
strongest effect of cholestasis was revealed to be at 24 hwhichwas
selected as the time interval between seizure induction and bile
duct ligation in this study. BDL and sham-operated groups were
injected PTZ (60 mg/kg) 24 h after operation and the same dosage
was injected to the control group. Since the dosage of PTZ was
changed (50–60 mg/kg) from experiment II to experiment III,
another groupwas injected dithizone (100 mg/kg) followed by PTZ
after 15 min. Eight pretreated mice with DMSO were also injected
PTZ (60 mg/kg) as the vehicle-injected group. The ﬁfth group of the
experiment was a BDL group which was injected dithizone
(100 mg/kg) followed by PTZ (60 mg/kg), 24 h after operation.
2.4. Assessment of seizure severity
After i.p. injection of PTZ, mice were observed in clear plastic
cages for 30 min and their behavioral seizure activities were scored
according to Table 1.27 The maximum behavioral response for each
mouse was namedMSSS. Death was scored as stage 6 only if it was
preceded by status epilepticus. Furthermore, the onset of showing
forelimb clonus seizure (score 3) or higher scores was considered as
‘‘forelimb clonus latency’’ (FCL), an independent index from MSSS.
2.5. Statistical analysis
AsMSSS did not follow the normal distribution a non-parametric
test (Kruskal–Wallis test) was used to test the overall effect of
dithizone and DEDTC dosage and time interval on MSSS. Also,
another non-parametric test (Mann–Whitney U-test) was used to
test the differences in the distribution of MSSS at different doses of
dithizone and DEDTC and time intervals between dithizone and PTZ
injections. Chi-square test was used to test for the association
between using dithizone or DEDTC and the incidence of a certain
MSSS.Whenever conditionswhich permit the use of Chi-square test
werenotprovided, Fisher’s exact testwasused.Data inall ﬁguresare
presented asmean S.E.M. A P value less than 0.05was considered as
statistically signiﬁcant. All statistical analyses were performed using
the SPSS software, version 13.0.
3. Results
One day after bile duct ligation, the animals revealed obvious
signs of cholestasis (jaundice, dark urine and steatorrhea) and
these signs persisted thereafter. The mortality rate was less than
10%.
3.1. Dithizone and DEDTC resulted in signiﬁcant dose-dependent
changes in MSSS
Figs. 1 and 2 Figs. 1A and 2A show that 100 and 200 mg/kg
dithizone and 50 and 100 mg/kg DEDTC signiﬁcantly increased the
Fig. 2. (A) Effects of different doses of DEDTC onmaximum seizure severity score in
mice. 0.9% saline and 50 mg/kg of PTZ were injected to vehicle and control groups,
respectively. (B) Percentage of mice responding with score 3, 5 and 6 seizures.
*P < 0.05 and **P < 0.01 compared to vehicle-injected group; ++P < 0.01 compared
to control group.
Fig. 1. (A) Effects of different doses of dithizone on maximum seizure severity score
in mice. DMSO and 50 mg/kg of PTZ were injected to vehicle and control groups,
respectively. (B) Percentage of mice responding with score 3, 5 and 6 seizures.
**P < 0.01 and ***P < 0.001 compared to vehicle-injected group; +P < 0.05 and
++P < 0.01 compared to control group.
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P < 0.01, respectively), while there was not any signiﬁcant
change of FCL by different doses of dithizone and DEDTC
(P > 0.05). DMSO and saline as vehicles did not change seizure
activity (Mann–WhitneyU-test, P > 0.05). No signiﬁcant effect on
MSSS was observed in 5 and 30 mg/kg dithizone-injected groups
(Mann–Whitney U-test, P > 0.05) and the minimal injected dose
which resulted in signiﬁcantly increased MSSS compared to
vehicle-injected group was 100 mg/kg (P < 0.01). Also, the effect
of 200 mg/kg dithizone on MSSS was highly signiﬁcant
(P < 0.001). 25 mg/kg DEDTC had no statistically signiﬁcant
effect on MSSS, while 50 mg/kg (P < 0.05) and 100 mg/kg
(P < 0.01) doses were accompanied by signiﬁcant changes in
seizure activity.
3.2. Incidences of different seizure severity scores followed the same
pattern as MSSS
The incidences of seizure severity scores 3, 5 and 6, among
different groups have been diagrammed in Figs. 1B and 2B. There
was a signiﬁcant increase in the incidences of score 3 (Chi-square
test, P < 0.01), scores 5 and 6 (Chi-square test, P < 0.001) due to
dithizone injection. 100 mg/kg dosage of dithizone increased the
incidence of score 5 (Fisher’s exact test, P < 0.01), whereas 200 mg/
kg dosage enhanced both scores 5 and 6 of seizure activities(Fisher’s exact test, P < 0.01). Also, incidence of score 3 showed
signiﬁcant increase compared to control group following 200 mg/
kg dithizone injection. DEDTC injection showed an increase only in
the incidence of score 5 (P < 0.001). Injection of 100 mg/kg DEDTC
was accompanied by increased incidence of score 5 compared to
vehicle-injected group (P < 0.01).
3.3. Time course study revealed no signiﬁcant role for time the interval
between dithizone injection and seizure induction
From the experiment II onward, the dithizone was chosen
between two metal chelating agents used in the experiment I.
For selecting a dose of dithizone among those used in the
experiment II, we compared the signiﬁcantly effective doses,
100 and 200 mg/kg. The dose of 200 mg/kg showed statistically
signiﬁcant increase in MSSS compared to the dose of 100 mg/kg
(P < 0.01). However, we were not to choose the most effective
dose because in the experiment I 7 out of 8 of 200 mg/kg
dithizone-injected mice showed score 6, the maximum score,
which meant this dose of dithizone (200 mg/kg) was not an ideal
dose for the time course study; because if changing the time was
going to increase seizure activity, this dose of dithizone would
have not been able to detect the difference. Thus, the dosage of
100 mg/kg was used in this stage of the study (time course
study).
Fig. 3. Different indices (i.e. MSSS, incidence and FCL) show decreased seizure
activity in BDL-mice, while this effect is suppressed by dithizone injection. DMSO
and 60 mg/kg of PTZ were injected to vehicle and control groups, respectively. (A)
Maximum seizure severity score increased in dithizone group (P < 0.05), decreased
in BDL group (P < 0.05) and in dithizone-injected BDL group it was at the level of
sham group (P > 0.05). (B) Percentage of mice responding with score 3, 5 and 6
seizures. (C) Forelimb clonus latency increased in BDL group while this
enhancement was suppressed in BDL-mice which were injected dithizone intra-
peritoneally. *P < 0.05 and **P < 0.01 compared to vehicle-injected group; +P < 0.05
and ++P < 0.01 compared to control group; XP < 0.05 and XXP < 0.01 compared to
sham-operated group; #P < 0.05 compared to BDL group.
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groups (Kruskal–Wallis test, P > 0.05) and therefore the 15 min
interval was chosen for the experiment III.
3.4. Cholestasis resulted in signiﬁcant decrease of MSSS which was
opposed by dithizone administration
Asmentioned earlier, the dosage of PTZwas changed from 50 to
60 mg/kg in experiment III. It is well known that cholestasis
decreases seizure activity and as the mice in control group, which
were injected 50 mg/kg, all showed stage 2 of seizure activity, it
was nearly impossible to expect any more decrease after
cholestasis. Thus, a dosage of PTZ was needed to increase the
seizure activity in control group to an average stage that can be
altered both positively and negatively by dithizone and bile duct
ligation, respectively. According to some pilot studies (data not
shown), the optimum dosage was 60 mg/kg. In another pilot study
different time intervals (24, 48, 72 and 120 h) between bile duct
ligation and PTZ-induced seizure were assessed to ﬁnd the optimal
time interval for the most effective inhibitory action of cholestasis
on seizure activity. Based on the result of this preliminary study,
the 24 h delay after bile duct ligation in assessing seizure activity
was accompanied by the most decreasing effect on MSSS in this
animal model of seizure (data not shown).
No signiﬁcant difference was detected between Sham and
control groups (Mann–Whitney U-test, P < 0.05), while this was
not the case about BDL mice group compared to control and Sham
groups (P < 0.05). As before, dithizone showed dramatic increase
in the seizure activity (P < 0.01). Being injected to BDL mice,
dithizone reversed the cholestasis-induced changes of seizure
activity (i.e. decreased MSSS) and no difference was observed
compared to control and Sham groups (P > 0.05), although it was
not effective enough to decrease MSSS to the level of BDL group
(P < 0.05) (Fig. 3A).
3.5. Incidences of different seizure severity scores were decreased in
BDL group, while these changes were eliminated by dithizone injection
Fig. 3B shows the incidences of three different seizure severity
scores in groups of experiment III. No difference was detected
among control, vehicle-injected (DMSO) and Sham groups in any of
these scores (Fisher’s exact test, P > 0.05).
3.5.1. Score 3
Percentage of mice that showed seizure severity score 3 was
higher in dithizone-injected mice compared to vehicle-injected
group (P < 0.05). Compared to Sham group, BDL group resulted in
lower incidence (P < 0.05), while its effect was decreased by
dithizone administration, as dithizone-injected BDL mice had
more score 3 incidence than BDL group.
3.5.2. Scores 5 and 6
Incidence of mice that showed score 5 was decreased in BDL
group and increased after dithizone injection, although neither
cholestasis nor dithizone injection resulted in signiﬁcant changes
(P > 0.05).
Dithizone highly enhanced the incidence of seizure severity
score 6 in comparison with vehicle-injected group (P < 0.01). On
the other hand, as control and Sham groups did not have any
mouse with seizure severity score 6, cholestasis which was
supposed to reduce the incidence of any scorewas not able to show
any difference. However, dithizone-injected BDL mice did not
show signiﬁcant increase in the incidence of score 6 compared to
Sham and BDL groups (P > 0.05), as the increasing effect of
dithizone had been suppressed by cholestasis.
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was decreased by dithizone injection
As discussed earlier, ‘‘forelimb clonus latency’’ was the interval
between injection of PTZ and onset of seizure activity of score 3 or
higher scores. Changes of FCL in the experiment III of the study are
shown in Fig. 3C. No signiﬁcant changes were caused by injection
of vehicle (DMSO) and sham operation compared to control group
(P > 0.05), whereas cholestasis prolonged FCL compared to sham
group (P < 0.05). Dithizone, which did not change FCL signiﬁcantly,
after being injected to BDL mice reduced FCL.
4. Discussion
In this study, we evaluated the effect of zinc chelating agents on
the seizure activity and assessed their ability to suppress the
cholestasis-induced alteration in the seizure activity. Our data
demonstrated that pretreatment with metal chelating agents,
dithizone and DEDTC, resulted in a dramatic dose-dependent
increase in the PTZ-induced seizure severity. On the other hand, we
showed that cholestasis-induced decrease in MSSS and incidences
of different seizure severity scores and increase in the forelimb
clonus latency were diminished by dithizone injection.
The increased PTZ-induced seizure severity score in dithizone-
injected mice in a dose-dependent manner suggests that the
overall effect of zinc is to dampen excitability. These preliminary
data in our study are consistentwith previous studies.Mitchell and
Barnes22 observed that intra-peritoneal injection of DEDTC in
doses more than 50 mg chelates endogenous zinc and lowers the
threshold of convulsion, when the rat hippocampal perforant
pathway was stimulated. Furthermore, DEDTC and dithizone were
found to augment the severity of kainic acid-induced seizures.22
Also, mice knocked out for ZnT3 (the gene encoding for zinc
transporter), which lacked histochemically reactive zinc in
synaptic vesicles, were more susceptible than wild-type (ZnT3+/
+) mice to kainic acid-induced seizures.27 All studies mentioned
above indicate a protective role for endogenous zinc. Considering
the fact that seizure activity is dependent on the balance between
the excitatory (e.g. NMDA) and inhibitory (e.g. GABAA) receptors,
the best described inhibitory effects of zinc are the antagonistic
effect on NMDA receptors38–40 (and the enhancement of GABA
release (perhaps by blocking GABAB autoreceptores) that produce
giant depolarizing potentials in CA3 region.41,42 On the other hand,
the present data revealed that the cholestasis-induced decrease in
MSSS and incidences of different seizure severity scores and
increase in the forelimb clonus latency were diminished by
dithizone injection. This result suggests that the enhanced seizure
threshold in cholstatic mice might be due to the changes in Zinc
concentration or content. However, this hypothesis is warranted
more detailed studies.
One question which arises is that whether or not the
enhancement of seizure activity by DEDTC and dithizone is due
to the Zinc chelation or to other actions of these compounds. For
example, DEDTC inhibits a variety of enzymes with crucial
sulfhydryl groups.43–45 However, this inhibition lasts for several
hours whereas the effect of a single dose of DEDTC on the chelation
of the histochemically reactive mossy ﬁber zinc is relatively short,
less than an hour.46 In the present study, we also evaluated the PTZ
seizure activity shortly after injection of metal chelators. In
addition, it has been shown that bursting of CA3 neurons in
hippocampus can readily be obtained following stimulation of the
mossy ﬁbers after perfusion of hippocampal slices by DEDTC;
replenishing the zinc in these slices prevents this effect of DEDTC.23
Thus the most parsimonious explanation for the lowering of
seizure threshold by these compounds appears to be chelation ofzinc. However, it should be noted that Jones et al. in 1992 have
shown that the zinc chelator DEDTC could induce a modest
decrease in the biliary and urinary excretion of copper but not
other trace elements such as magnesium, calcium and iron.47
Therefore, more detailed studies are clearly needed to examine
whether the dithizone-induced alteration in the seizure activity of
cholestatic mice is due to its speciﬁc effect on the zinc content or
not.
It is well known that cholestasis could result in several
alterations among which, of our interest, are elevated hepatic
and plasma levels of zinc,33 NO overproduction in cholestatic
condition30,31,48 and increased plasma levels of endogenous
opioids.49,50 On the other hand, some studies have reported that
NO generators can produce accumulation of chelatable zinc.28,51,52
Moreover, there is increasing evidence of the interaction between
zinc and opioidergic system; Tejwani and Hanissian35 reported
that physiological concentrations of zinc were inhibitory to mu-
opioid receptor binding. A recent study reported that cholestasis-
induced increase in clonic seizure thresholdwas, in part, reversible
by opioid antagonists and NOS inhibitors.32,37 Based on these
reports, our ﬁnding of the effect of dithizone on cholestasis-
induced changes of seizure activity suggests that in addition to NO
and opioid systems zinc also plays a role in the cholestasis-induced
seizure threshold. However, it remains to be explained whether
alteration of zinc homeostasis follows either opioids or NO, or vice
versa; as a result, further studies seem to be necessary.
It is possible that markedly decreased permeability of blood–
brain barrier, which is well conﬁrmed in cholestasis,53 reduces the
rate of passage of PTZ and can explain the increased lag phase
before seizure in the BDL group in this study. This ﬁnding is in
agreement with a previous study that also showed enhanced
latency of the onset of seizure after bile duct ligation.54 As
dithizone could also decrease the increased latency of onset of
seizure, it suggests a role for zinc in the function of blood–brain
barrier.
5. Conclusion
In conclusion, the present study shows that bile duct ligation
decreases seizure activity. As the effect of BDL on seizure activity is
diminished by dithizone administration, elevated plasma levels of
zinc and the possible increase in brain zinc content may have been
involved. Our ﬁndings suggest a probable increase of zinc in
cholestatic state which would play some role in cholestasis-
induced alterations of seizure severity. These ﬁndings fulﬁlled our
expectations of this study and encouraged us to stride for further
studies in the hope of ﬁnding more evidence about the relations
between cholestasis and zinc.
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